+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Immunotherapy"

Antibody Drug Conjugate - Competitive Landscape, 2025 - Product Thumbnail Image

Antibody Drug Conjugate - Competitive Landscape, 2025

  • Report
  • March 2025
  • 450 Pages
  • Global
From
TCR Therapy - Pipeline Insight, 2025 - Product Thumbnail Image

TCR Therapy - Pipeline Insight, 2025

  • Drug Pipelines
  • March 2025
  • 280 Pages
  • Global
From
From
Peanut Allergy - Pipeline Insight, 2024 - Product Thumbnail Image

Peanut Allergy - Pipeline Insight, 2024

  • Clinical Trials
  • December 2024
  • 60 Pages
  • Global
From
Pheochromocytoma- Pipeline Insight, 2024 - Product Thumbnail Image

Pheochromocytoma- Pipeline Insight, 2024

  • Drug Pipelines
  • August 2024
  • 60 Pages
  • Global
From
From
Squamous Cell Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Squamous Cell Carcinoma - Pipeline Insight, 2024

  • Drug Pipelines
  • July 2024
  • 240 Pages
  • Global
From
Biliary Tumor - Pipeline Insight, 2024 - Product Thumbnail Image

Biliary Tumor - Pipeline Insight, 2024

  • Clinical Trials
  • July 2024
  • 180 Pages
  • Global
From
From
Toll-Like Receptor 8 Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Toll-Like Receptor 8 Agonist - Pipeline Insight, 2024

  • Drug Pipelines
  • July 2024
  • 60 Pages
  • Global
From
IPSC derived NK cells - Pipeline Insight, 2024 - Product Thumbnail Image

IPSC derived NK cells - Pipeline Insight, 2024

  • Drug Pipelines
  • July 2024
  • 60 Pages
  • Global
From
Alopecia Areata - Pipeline Insight, 2024 - Product Thumbnail Image

Alopecia Areata - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 80 Pages
  • Global
From
Advanced liver cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Advanced liver cancer - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 180 Pages
  • Global
From
From
Birch Pollen Allergy - Pipeline Insight, 2024 - Product Thumbnail Image

Birch Pollen Allergy - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Food Allergy - Pipeline Insight, 2024 - Product Thumbnail Image

Food Allergy - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
HER2-positive Gastric Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

HER2-positive Gastric Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 80 Pages
  • Global
From
Head and Neck Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Head and Neck Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 230 Pages
  • Global
From
Atypical Teratoid Rhabdoid Tumors (ATRT) - Pipeline Insight, 2024 - Product Thumbnail Image

Atypical Teratoid Rhabdoid Tumors (ATRT) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Loading Indicator

Immunotherapy is a type of treatment used to treat immune disorders, such as allergies, asthma, and autoimmune diseases. It works by stimulating the body's own immune system to fight off disease-causing agents. Immunotherapy drugs are designed to target specific parts of the immune system, such as T-cells, B-cells, and cytokines. These drugs can be used to treat a variety of conditions, including cancer, HIV/AIDS, and rheumatoid arthritis. Immunotherapy drugs are typically administered through injections, infusions, or oral medications. They can also be used in combination with other treatments, such as chemotherapy or radiation therapy. The goal of immunotherapy is to reduce the severity of symptoms and improve the patient's quality of life. The immunotherapy market is a rapidly growing sector of the pharmaceutical industry. Companies in this market are focused on developing new treatments and therapies to treat immune disorders. Some of the major players in this market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, and Pfizer. Show Less Read more